Ceprohart Income Statement

Financials in millions RON. Fiscal year is January - December.

Millions RON. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Jan '24 Jan 1, 2024	Jan '23 Jan 1, 2023	Jan '22 Jan 1, 2022
Operating Revenue	4.5	6.98	3.29	7.26	6.1
Other Revenue	-	0	-	-	-
Revenue	4.5	6.98	3.29	7.26	6.1
Revenue Growth (YoY)	-35.59%	112.00%	-54.68%	19.10%	5.68%
Cost of Revenue	3.15	4.86	3.74	5.51	4.65
Gross Profit	1.34	2.12	-0.45	1.76	1.45
Selling, General & Admin	0.02	0.02	0.01	0.03	-
Other Operating Expenses	1.01	1.03	0.6	1.01	1.15
Operating Expenses	1.22	1.24	0.8	1.24	1.33
Operating Income	0.13	0.89	-1.25	0.52	0.12
Interest Expense	-0.06	-0.07	-0.13	-0.14	-0.09
Interest & Investment Income	0	0	0	0	0
Other Non Operating Income (Expenses)	-0	-0	-0	-0	-0
Pretax Income	0.06	0.82	-1.38	0.38	0.03
Income Tax Expense	0.01	0.04	-	0.07	0.02
Net Income	0.05	0.77	-1.38	0.31	0.01
Net Income to Common	0.05	0.77	-1.38	0.31	0.01
Net Income Growth	-93.12%	-	-	2822.01%	-
Shares Outstanding (Basic)	0	0	0	0	0
Shares Outstanding (Diluted)	0	0	0	0	0
EPS (Basic)	0.19	2.77	-4.95	1.10	0.04
EPS (Diluted)	0.19	2.77	-4.95	1.10	0.04
EPS Growth	-93.12%	-	-	2822.01%	-
Gross Margin	29.86%	30.40%	-13.64%	24.19%	23.74%
Operating Margin	2.79%	12.68%	-37.99%	7.10%	2.01%
Profit Margin	1.18%	11.07%	-41.96%	4.24%	0.17%
EBITDA	0.32	1.07	-1.06	0.72	0.3
EBITDA Margin	7.03%	15.34%	-32.13%	9.86%	4.84%
D&A For EBITDA	0.19	0.19	0.19	0.2	0.17
EBIT	0.13	0.89	-1.25	0.52	0.12
EBIT Margin	2.79%	12.68%	-37.99%	7.10%	2.01%
Effective Tax Rate	11.33%	5.32%	-	18.10%	63.09%
Revenue as Reported	6.16	7.12	3.32	7.18	5.96